EUVIMEDEUVIMED entdecken
Validierungsstudie

A universal immunocapture LC−MS/MS method for humanized IgG1−based drugs in cynomolgus monkeys

Pei Pang, Pingping Yin, Yimin Tao, Jinchuan Hong, Junjiu Xu, Wenhui Lin, Qiuping Qin, Likun Gong

Journal of Pharmaceutical and Biomedical Analysis · 2026-08 · 276 · 117461

DOI: 10.1016/j.jpba.2026.117461 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026-08. Verfasst von Pei Pang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Technology, China; Department of Clinical Chemistry and Immunoassay, Center for Drug Safety Evaluation and Research, Shanghai I…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Immunoglobulin G, Liquid Chromatography-Mass Spectrometry, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The application of immunocapture LC-MS/MS in drug testing has expanded considerably over the past decade, offering significant advantages in analysis, development, and identification. In this study, we developed and validated a universal immunocapture LC-MS/MS assay for the detection of humanized IgG1-based drugs in cynomolgus monkey sera. The method selected a 12-amino acid characteristic peptide from the CH1 region of IgG1 as a quantification surrogate and used the heavy stable isotope-labeled same peptide as an internal standard. Furthermore, humanized IgG1-based drugs were immunocaptured using magnetic streptavidin beads pre-bound to biotinylated anti-human IgG1 Fc antibodies, followed by trypsin digestion. The related liquid chromatography was conducted on a Shiseido C18 column (2.0 mm × 100 mm, 3 μm) equipped on a Shimadzu Nexera X2 UHPLC system. Quantification of the humanized IgG1 -based drugs was performed on a LCMS-8050 triple quadrupole mass spectrometer using multiple reaction monitoring (MRM) mode with positive electrospray ionization. The developed assay was validated for parameters including calibration curve, precision, accuracy, selectivity, recovery, and stability. The obtained results all met the acceptance criteria valid for ligand-binding assays (LBAs). Besides, involving humanized IgG1 -based drugs exhibited good stability in cynomolgus monkey sera under different tested conditions. After validation, the assay was successfully applied to the pharmacokinetic studies of two humanized IgG1-based antibody-drug conjugates (ADCs), respectively, generating comparable pharmacokinetic profiles to related LBAs. Together, the results confirm the assay's reliability, universality, and feasibility for quantifying the target drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryImmunoglobulin GLiquid Chromatography-Mass SpectrometryAntibodies, Monoclonal, HumanizedAnimalsMacaca fascicularisHumansReproducibility of ResultsChromatography, High Pressure LiquidCalibrationChromatography, Liquid

Stichwörter der Autor:innen

ADCHumanizedIgG1Internal StandardLBALC−MS/MSSurrogate peptide

Substanzen

Immunoglobulin GAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Shanghai Institute of Technology, China; Department of Clinical Chemistry and Immunoassay, Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 2012…
  • Nanjing University of Chinese Medicine, Nanjing 210023, China; Department of Clinical Chemistry and Immunoassay, Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of S…
  • Department of Clinical Chemistry and Immunoassay, Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Department of Formulation and Bioanalysis, Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Shanghai Institute of Technology, China. Electronic address: linwh@sit.edu.cn.
  • Department of Clinical Chemistry and Immunoassay, Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: qpqin@cdse…

Zitieren

APA

Pang, P., Yin, P., Tao, Y., Hong, J., Xu, J., Lin, W., Qin, Q., & Gong, L. (2026). A universal immunocapture LC−MS/MS method for humanized IgG1−based drugs in cynomolgus monkeys. Journal of Pharmaceutical and Biomedical Analysis, 276, 117461. https://doi.org/10.1016/j.jpba.2026.117461

Vancouver

Pang P, Yin P, Tao Y, Hong J, Xu J, Lin W, et al. A universal immunocapture LC−MS/MS method for humanized IgG1−based drugs in cynomolgus monkeys. Journal of Pharmaceutical and Biomedical Analysis. 2026;276:117461. doi:10.1016/j.jpba.2026.117461

BibTeX
@article{Pang2026,
  author = {Pang, Pei and Yin, Pingping and Tao, Yimin and Hong, Jinchuan and Xu, Junjiu and Lin, Wenhui and Qin, Qiuping and Gong, Likun},
  title = {A universal immunocapture LC−MS/MS method for humanized IgG1−based drugs in cynomolgus monkeys},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2026},
  volume = {276},
  pages = {117461},
  doi = {10.1016/j.jpba.2026.117461}
}
Kostenlos starten →